Una web app come strumento previsionale, a supporto delle centrali d’acquisto per il calcolo realistico del fabbisogno farmaceutico nella gestione degli appalti pubblici. La proposta delle aziende: accordo quadro multi-aggiudicatario per scongiurare le carenze.
SEOUL, South Korea and LONG BEACH, Calif., June 6, 2023 /PRNewswire/ -- A recent transnational questionnaire study conducted by the Institute of Digital Dentistry(iDD) has recognized the Medit i700 wireless and Medit i700 as the top two intraoral scanners in dentistry. Furthermore, the study ranked the Medit i600 among the top four scanners. This groundbreaking research involved 1,072 respondents from 109 different countries and spanned over three quarters.
Companies modernizing TMF management to drive automation and speed
MONTREAL, June 5, 2023 /PRNewswire/ -- Paraza Pharma is pleased to announce the appointment of Edward W. (Ted) Marple, A.B. (Harvard), MBA (Virginia) as Executive Vice-President, Development. Mr. Marple, who has more than 20 years of experience as a senior executive with broad skill sets across clinical development, IP protection, manufacturing, operations, company and product strategy, finance, and commercial partnering/development in the biotechnology and pharmaceutical industry.
JOHNSON CITY, Tenn. and COLOGNE, Germany, May 31, 2023 /PRNewswire/ -- Labor Dr. Wisplinghoff and LabConnect announced today the start of their strategic alliance to provide high quality and tailormade central laboratory services in Europe to support clinical trials around the world.
Nuovi sistemi di assemblaggio robotizzato per pompe volumetriche e macchina riempitrice con piattaforma servo-assistita
NASDAQ | TSX: ACB
MUMBAI, India and SIENA, Italy, May 30, 2023 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO), (Bloomberg: SUNP IN), (NSE: SUNPHARMA), (BSE: 524715) (together with its subsidiaries and/or associated companies, "Sun Pharma") and Philogen S.p.A (BIT: PHIL) today announced that they have entered into a licensing agreement for commercializing Philogen's specialty product, Nidlegy™ (Daromun) in the territories of Europe, Australia and New Zealand. Nidlegy™, currently in Phase II...
I benefici del minerale trasformato in colloidale puro ricoprono numerosi ambiti di applicazione
VANCOUVER, BC, May 17, 2023 /PRNewswire/ -- Performance BioFilaments Inc. is pleased to announce the start-up of the world's largest nanofibrillated cellulose (NFC) commercial production plant at Resolute's Forest Products, Kénogami paper mill in Quebec. A daily production capacity of 21 metric tons is now available to supply customers for commercial orders in concrete and mortar, nonwoven, industrial fluid, biocomposite plastic, thin film and mineral consolidation applications. A small dose of t...
LAWRENCEVILLE, N.J., May 16, 2023 /PRNewswire/ -- Datacolor AG, a global leader in color management solutions, announces the acquisition of matchmycolor LLC, a technology company specialized in color formulation and communication software. Datacolor consolidates matchmycolor as of January 1, 2023. The costs for the acquisition and the integration will affect the fiscal years 2022/23 and 2023/24. The strategic acquisition strengthens Datacolor's market position and further expands its global indus...
I dati dei rapporti annuali sul mercato italiano dei generici e dei biosimilari. L’allarme della filiera europea su rischio irreversibile di carenze.
BEIJING, May 15, 2023 /PRNewswire/ -- Wanhua Chemical ("Wanhua" or "the Company"; 600309.SS), along with other representatives from China and France, signed a three-party cooperative agreement recently to collaborate on Wanhua Chemical's Penglai Industrial Park seawater desalination project. The signing ceremony was held in Beijing at the fifth meeting of the Council of China-France Entrepreneurs, an official event for French President Emmanuel Macron's visit to China.
JINAN, China, May 12, 2023 /PRNewswire/ -- On May 8, 2023, Journal of Hematology & Oncology (JHO, 2022 impact factor of 23.168) published the results of the Phase I clinical study of Qilu Pharma's immunotherapy bifunctional antibody, QL1706 (J Hematol Oncol. 2023 May 8;16(1):50). This study is the first large Phase I clinical trial of QL1706 in humans, and was led by Prof. Li Zhang and his team at Sun Yat-sen University Cancer Center. The results provide further support for the use of dual immuno...
PARIS, May 10, 2023/PRNewswire/ -- Servier, a global pharmaceutical group, today announced that the European Commission (EC) has approved Tibsovo® (ivosidenib tablets) as a targeted therapy in two indications: in combination with azacitidine for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) with an isocitrate dehydrogenase-1 (IDH1) R132 mutation who are not eligible to receive standard induction chemotherapy; as well as in monotherapy for the treatment of adult...
In the news release, Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter, issued 09-May-2023 by Croma-Pharma over PR Newswire, we are advised by the company that the footnote [1] has been updated. The complete, corrected release follows:
VIENNA, May 9, 2023 /PRNewswire/ -- Croma-Pharma GmbH (Croma) today announced its 2022 financial results. 2022 was shaped by strong year-on-year revenue growth of 27% (total reported revenue rose from €95.8 million in 2021 to €121.2 million in 2022) which is believed to be the beginning of a period of rapid revenue growth fuelled by the future launch of new products, international expansion and strong overall market growth. The 2022 results were also driven by the launch of the new product Letybo...
GAITHERSBURG, Md., May 9, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its COVID-Influenza Combination (CIC), stand-alone influenza and high-dose COVID vaccine candidates all showed a reassuring preliminary safety profile as well as comparable reactogenicity to individual Novavax influenza and COVID vaccine candidates or authorized influenza vaccine comparators. Additionally, all three ...
Walsh brings nearly 30 years of experience managing global operations
SHANGHAI, May 7, 2023 /PRNewswire/ -- Cheng shin Rubber (Xiamen) IND., LTD. ("CST"), a leading manufacturer of two-wheeled tires, has launched CST COREX, an innovative product built with ECO-RE technology at the 31st China International Bicycle Fair (China Cycle 2023).
